NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


Don't have an account? Subscribe

Orkambi now available to children aged 6-11

By Mindo - 15th Mar 2018

Minister Harris pointed out that Ireland becomes one of the first countries in the European Union to provide access to Orkambi for children in this age range.

“It’s very positive news that Orkambi is now licenced and available for reimbursement in Ireland for CF patients aged six to 11,” Minister Harris said.

“Orkambi was already licenced and available for reimbursement for children aged 12 years and over.

“The extension to the younger children became possible following EMA approval in January of this year. “

The 2017 agreement between the manufacturer Vertex Pharmaceuticals and the HSE included the extension to other age groups, subject to market authorisation in Europe.

“This quick turnaround between approval and availability was possible because we ensured the younger age group was included in the agreement with the company Vertex last year, subject to market authorisation in Europe,” said Minister Harris.

“I am very pleased that Ireland is one of the first countries in the European Union to provide access to Orkambi for children in this age category.”

Leave a Reply

Latest
Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read